HUE042239T2 - Tamoxifen deriváltok neoplasztikus betegségek gyógyításához, fõként magasabb HER2 proteinszinttel - Google Patents
Tamoxifen deriváltok neoplasztikus betegségek gyógyításához, fõként magasabb HER2 proteinszinttelInfo
- Publication number
- HUE042239T2 HUE042239T2 HUE14721738A HUE14721738A HUE042239T2 HU E042239 T2 HUE042239 T2 HU E042239T2 HU E14721738 A HUE14721738 A HU E14721738A HU E14721738 A HUE14721738 A HU E14721738A HU E042239 T2 HUE042239 T2 HU E042239T2
- Authority
- HU
- Hungary
- Prior art keywords
- treatment
- protein level
- neoplastic diseases
- her2 protein
- high her2
- Prior art date
Links
- 101100314454 Caenorhabditis elegans tra-1 gene Proteins 0.000 title 1
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical class C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000001613 neoplastic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5456—Arylalkanephosphonium compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5442—Aromatic phosphonium compounds (P-C aromatic linkage)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5449—Polyphosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
- C09B23/0025—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being bound through an oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/14—Styryl dyes
- C09B23/141—Bis styryl dyes containing two radicals C6H5-CH=CH-
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/001—Dyes containing an onium group attached to the dye skeleton via a bridge
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B69/00—Dyes not provided for by a single group of this subclass
- C09B69/008—Dyes containing a substituent, which contains a silicium atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ2013-308A CZ2013308A3 (cs) | 2013-04-24 | 2013-04-24 | Deriváty tamoxifenu účinné proti nádorům, zejména s vyšší hladinou proteinu HER2 |
CZ2014-66A CZ305571B6 (cs) | 2014-01-29 | 2014-01-29 | Deriváty tamoxifenu k léčbě neoplastických chorob, zejména s vyšší hladinou proteinu HER2 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE042239T2 true HUE042239T2 (hu) | 2019-06-28 |
Family
ID=50677895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE14721738A HUE042239T2 (hu) | 2013-04-24 | 2014-04-07 | Tamoxifen deriváltok neoplasztikus betegségek gyógyításához, fõként magasabb HER2 proteinszinttel |
Country Status (22)
Country | Link |
---|---|
US (1) | US9896466B2 (hu) |
EP (1) | EP2989110B1 (hu) |
JP (1) | JP6375091B2 (hu) |
KR (1) | KR101764991B1 (hu) |
CN (1) | CN105452265B (hu) |
AU (1) | AU2014256546B2 (hu) |
CA (1) | CA2909994C (hu) |
CY (1) | CY1120821T1 (hu) |
DK (1) | DK2989110T3 (hu) |
EA (1) | EA029881B1 (hu) |
ES (1) | ES2699099T3 (hu) |
GE (1) | GEP20186868B (hu) |
HK (1) | HK1216317A1 (hu) |
HR (1) | HRP20181872T1 (hu) |
HU (1) | HUE042239T2 (hu) |
MD (1) | MD4626C1 (hu) |
NZ (1) | NZ713589A (hu) |
PL (1) | PL2989110T3 (hu) |
PT (1) | PT2989110T (hu) |
SI (1) | SI2989110T1 (hu) |
UA (1) | UA116469C2 (hu) |
WO (1) | WO2014173374A1 (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10548318B2 (en) * | 2015-07-03 | 2020-02-04 | Bayer Cropscience Aktiengesellschaft | N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide derivatives with herbicidal action |
BR112018000088B1 (pt) * | 2015-07-03 | 2022-07-12 | Bayer Cropscience Aktiengesellschaft | Derivados de n-(1,3,4-oxadiazol-2-il)aril carboxamida com ação herbicida, seu uso, composição herbicida, e método para controle de plantas indesejadas |
CA3030411A1 (en) * | 2016-07-12 | 2018-01-18 | Accutar Biotechnology Inc. | Novel compounds and uses thereof |
US11040019B2 (en) | 2016-08-19 | 2021-06-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Selective estrogen-receptor modulators (SERMs) confer protection against photoreceptor degeneration |
EP3330274A1 (en) * | 2016-12-01 | 2018-06-06 | Springtide Ventures s.r.o. | Compounds for treatment of senescence-related disorders |
WO2018195434A1 (en) | 2017-04-21 | 2018-10-25 | Lisanti Michael P | Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (cscs) |
US11229657B2 (en) | 2017-04-21 | 2022-01-25 | Lunella Biotech, Inc. | Targeting hypoxic cancer stem cells (CSCs) with doxycycline: implications for improving anti-angiogenic therapy |
RU2019142102A (ru) | 2017-05-19 | 2021-06-21 | Лунелла Байотек, Инк. | Антимитосцины: направленные ингибиторы митохондриального биогенеза для эрадикации злокачественных стволовых клеток |
BR112020008022A2 (pt) | 2017-10-24 | 2020-10-27 | Lunella Biotech, Inc. | mitoflavoscinas: o direcionamento de enzimas contendo flavina elimina as células-tronco de câncer (cscs) por meio da inibição da respiração mitocondrial |
JP7066847B2 (ja) | 2017-11-24 | 2022-05-13 | ルネラ・バイオテック・インコーポレーテッド | がん幹細胞を根絶するトリフェニルホスホニウム誘導体化合物 |
US11497759B2 (en) | 2017-12-01 | 2022-11-15 | Lunella Biotech, Inc. | Repurposcins: targeted inhibitors of mitochondrial biogenesis for eradicating cancer stem cells |
WO2019113210A1 (en) | 2017-12-05 | 2019-06-13 | Anthos Partners, Lp | Phosphonium-based ionic drug conjugates |
US11559527B2 (en) | 2017-12-20 | 2023-01-24 | Lunella Biotech, Inc. | Targeting mitochondrial fission through mDIVI-1 derivatives |
KR20210152500A (ko) * | 2019-04-16 | 2021-12-15 | 루넬라 바이오테크 인코포레이티드 | 미토콘드리아 표적화용 알킬-tpp 화합물 및 항암 치료 |
EP3753944A1 (en) | 2019-06-17 | 2020-12-23 | Institute Of Biotechnology Cas, V.V.I. | 3,5-bis(phenyl)-1h-heteroaryl derivatives as medicaments |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1289570C (en) * | 1986-06-16 | 1991-09-24 | Tetsuji Asao | 1,1,2-triaryl-1-alkene derivatives |
CA2092996A1 (en) * | 1990-10-01 | 1992-04-02 | David Yang | High affinity tamoxifen derivatives and uses thereof |
JP3635708B2 (ja) * | 1995-03-06 | 2005-04-06 | 出光興産株式会社 | 有機エレクトロルミネッセンス素子 |
TWI309571B (en) * | 2002-12-31 | 2009-05-11 | Ind Tech Res Inst | Delivery carrier for targeting cells haring over-expressed estrogen |
JP4648319B2 (ja) * | 2003-08-22 | 2011-03-09 | アンティポディーン ファーマシューティカルズ インコーポレイティド | ミトコンドリアを標的とする抗酸化剤として使用されるミトキノン誘導体 |
SG156613A1 (en) * | 2004-07-13 | 2009-11-26 | Oridis Biomed Forschungs Und E | Use of mitochondrially targeted antioxidant in the treatment of liver diseases and epithelial cancers |
WO2009111846A1 (en) * | 2008-03-14 | 2009-09-17 | Stephen John Ralph | Mitochondrially delivered anti-cancer compounds |
MX2011010956A (es) * | 2009-04-17 | 2012-01-27 | Colby Pharmaceutical Company | Composiciones farmaceuticamente activas que comprenden moduladores de estres oxidativo (osm por sus siglas en inglés), nuevas entidades quimicas, composiciones y usos. |
WO2011129837A1 (en) * | 2010-04-16 | 2011-10-20 | Olema Pharmaceuticals, Inc. | Use of a 4-hydroxytoremifene prodrug for treatment of breast cancer |
-
2014
- 2014-04-07 NZ NZ713589A patent/NZ713589A/en unknown
- 2014-04-07 CA CA2909994A patent/CA2909994C/en active Active
- 2014-04-07 MD MD20150117A patent/MD4626C1/ro active IP Right Grant
- 2014-04-07 UA UAA201510642A patent/UA116469C2/uk unknown
- 2014-04-07 SI SI201430928T patent/SI2989110T1/sl unknown
- 2014-04-07 WO PCT/CZ2014/000035 patent/WO2014173374A1/en active Application Filing
- 2014-04-07 AU AU2014256546A patent/AU2014256546B2/en active Active
- 2014-04-07 PL PL14721738T patent/PL2989110T3/pl unknown
- 2014-04-07 US US14/786,710 patent/US9896466B2/en active Active
- 2014-04-07 JP JP2016509298A patent/JP6375091B2/ja active Active
- 2014-04-07 PT PT14721738T patent/PT2989110T/pt unknown
- 2014-04-07 KR KR1020157030376A patent/KR101764991B1/ko active IP Right Grant
- 2014-04-07 DK DK14721738.4T patent/DK2989110T3/en active
- 2014-04-07 ES ES14721738T patent/ES2699099T3/es active Active
- 2014-04-07 HU HUE14721738A patent/HUE042239T2/hu unknown
- 2014-04-07 EP EP14721738.4A patent/EP2989110B1/en active Active
- 2014-04-07 EA EA201591918A patent/EA029881B1/ru unknown
- 2014-04-07 CN CN201480033316.9A patent/CN105452265B/zh active Active
-
2015
- 2015-04-07 GE GEAP201513996A patent/GEP20186868B/en unknown
-
2016
- 2016-04-14 HK HK16104277.8A patent/HK1216317A1/zh unknown
-
2018
- 2018-11-06 CY CY181101155T patent/CY1120821T1/el unknown
- 2018-11-08 HR HRP20181872TT patent/HRP20181872T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2014173374A1 (en) | 2014-10-30 |
EA201591918A1 (ru) | 2016-02-29 |
CA2909994A1 (en) | 2014-10-30 |
CN105452265B (zh) | 2017-05-10 |
ES2699099T3 (es) | 2019-02-07 |
CA2909994C (en) | 2018-06-26 |
EA029881B1 (ru) | 2018-05-31 |
MD4626B1 (ro) | 2019-04-30 |
US9896466B2 (en) | 2018-02-20 |
HRP20181872T1 (hr) | 2019-02-08 |
HK1216317A1 (zh) | 2016-11-04 |
JP6375091B2 (ja) | 2018-08-15 |
KR20150144756A (ko) | 2015-12-28 |
SI2989110T1 (sl) | 2019-01-31 |
MD4626C1 (ro) | 2019-11-30 |
CY1120821T1 (el) | 2019-12-11 |
AU2014256546B2 (en) | 2017-03-30 |
DK2989110T3 (en) | 2018-12-03 |
CN105452265A (zh) | 2016-03-30 |
NZ713589A (en) | 2017-12-22 |
EP2989110A1 (en) | 2016-03-02 |
JP2016522179A (ja) | 2016-07-28 |
MD20150117A2 (ro) | 2016-08-31 |
AU2014256546A1 (en) | 2015-11-12 |
PT2989110T (pt) | 2018-11-15 |
UA116469C2 (uk) | 2018-03-26 |
KR101764991B1 (ko) | 2017-08-10 |
US20160075726A1 (en) | 2016-03-17 |
PL2989110T3 (pl) | 2019-03-29 |
GEP20186868B (en) | 2018-06-25 |
EP2989110B1 (en) | 2018-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20181872T1 (hr) | Derivati tamoksifena za liječenje neoplastičnih bolesti, posebice s višom razinom proteina her2 | |
HK1221646A1 (zh) | 高劑量普利多匹定用於治療亨廷頓舞蹈症的用途 | |
HK1219486A1 (zh) | 用於治療癌症的涉及抗密蛋白 的抗體的療法 | |
IL243976B (en) | kdm1a inhibitors for disease treatment | |
EP3033079A4 (en) | Methods for the treatment of her2 amplified cancer | |
HK1213886A1 (zh) | 用於治療心血管疾病的 -哌啶- -基苯甲酰胺衍生物 | |
HK1219653A1 (zh) | 治療線粒體疾病的方法 | |
PT3089749T (pt) | Preparações combinadas para o tratamento de cancro | |
EP3007756A4 (en) | Catheter-assisted tumor treatment | |
HK1222548A1 (zh) | 治療惡性腫瘤的藥物組合 | |
EP2967062A4 (en) | DESETHYLHYDROXYCHLOROQUIN FOR THE TREATMENT OF DISEASES RELATED TO INFLAMMATION | |
EP2959903A4 (en) | MEDICAMENT FOR THE TREATMENT OF EYE DRESSING | |
GB201314386D0 (en) | Treatment system for aquaculture | |
IL244755A0 (en) | process to create xanthohumol | |
HK1223547A1 (zh) | 癌症治療方法 | |
HUE040536T2 (hu) | Eljárás halogén-N,N-dimetilbenzilaminok elõállítására | |
PL2976360T3 (pl) | Terapia obejmująca przeciwciała przeciwko klaudynie 18.2 do leczenia nowotworu złośliwego | |
EP3047857A4 (en) | Treatment for hemorrhagic diseases by anti-protein-c antibody | |
EP2976078A4 (en) | TREATMENT OF CHEMOTHERAPY-RELATED PERIPHERAL NEUROPATHY | |
EP2949329A4 (en) | THERAPEUTIC AGAINST DEMYELINISING DISEASE | |
EP3016948B8 (en) | 2-acylaminothiazoles for the treatment of cancer | |
HK1224215A1 (zh) | 高劑量普利多匹定用於治療亨廷頓舞蹈症的用途 | |
GB201506512D0 (en) | Retinal sleep lamp V2 | |
GB201306413D0 (en) | The local treatment of ophthalmic diseases | |
AU2013904239A0 (en) | Pharmaceutical combinations for the treatment of cancer |